I

InterCure Ltd
TASE:INCR

Watchlist Manager
InterCure Ltd
TASE:INCR
Watchlist
Price: 498.2 ILS -5.46% Market Closed
Market Cap: 239.6m ILS
Have any thoughts about
InterCure Ltd?
Write Note

Wall Street
Price Targets

INCR Price Targets Summary
InterCure Ltd

There are no price targets for INCR.
Lowest
Price Target
Not Available
Average
Price Target
Not Available
Highest
Price Target
Not Available
InterCure Ltd Competitors:
Price Targets
13
HUTCHMED (China) Ltd
49% Upside
HROW
Harrow Health Inc
45% Upside
AMPH
Amphastar Pharmaceuticals Inc
32% Upside
600993
Mayinglong Pharmaceutical Group Co Ltd
53% Upside
688185
CanSino Biologics Inc
1% Upside
IPN
Ipsen SA
18% Upside
600566
Hubei Jumpcan Pharmaceutical Co Ltd
88% Upside

Revenue
Forecast

Revenue Estimate
InterCure Ltd

The compound annual growth rate of InterCure Ltd's revenue for the next 3 years is 17%.

N/A
Past Growth
17%
Estimated Growth
Estimates Accuracy
-2%
Average Miss

Operating Income
Forecast

Operating Income Estimate
InterCure Ltd

The compound annual growth rate of InterCure Ltd's operating income for the next 3 years is 40%.

N/A
Past Growth
40%
Estimated Growth
Estimates Accuracy
N/A
Average

Net Income
Forecast

Net Income Estimate
InterCure Ltd

N/A
Past Growth
N/A
Estimated Growth
Estimates Accuracy
-1%
Average Miss

See Also

Discover More
Why do you have more estimates than other sites?

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is INCR's stock price target?
Not Available

INCR doesn't have any price targets made by Wall Street professionals.

What is InterCure Ltd's Revenue forecast?
Projected CAGR
17%

The compound annual growth rate of InterCure Ltd's revenue for the next 3 years is 17%.

What is InterCure Ltd's Operating Income forecast?
Projected CAGR
40%

The compound annual growth rate of InterCure Ltd's operating income for the next 3 years is 40%.

Back to Top